🌊 Social🇮🇳 India
US Cuts HIV Funding in Africa — And Indian Pharmaceutical Companies Are Watching
NPR·Sunday, 7 June 2026
The Trump administration has cut or redirected PEPFAR funding — the US programme that provides AIDS treatment across Africa. Health workers in South Africa and Mozambique say people are already dying because of the funding gaps. India is the world's largest supplier of generic HIV drugs to Africa, and demand shifts could hit Indian pharma exports.
Why It Matters
India's generic drug industry supplies over 70% of HIV medicines used in Africa. Any shake-up in how Africa funds its HIV response directly affects Indian pharmaceutical companies.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.
More from Social
- India's $9 Billion Bet on Great Nicobar Is Bulldozing One of Earth's Last Wild Places
- Ebola's Shadow Over India: Why the DRC Outbreak Is a Story Indians Should Follow
- China Tried to Compromise a British Researcher Investigating Its Organised Crime Links
- Ebola Could Hit 2014 Scale — US Health Officials Sound the Alarm